Your current region: US

Management Team

Page Header Image

Angelo Moesslang, PhD
Chief Executive Officer

Angelo Moesslang, PhD, is Chief Executive Officer of InGeneron. He has 20 years of leadership experience and a proven track record as a finance and healthcare executive in the medical device industry. Prior to joining InGeneron, he was CFO of Fresenius Medical Care North America Holdings, the US-based division of Fresenius Medical Care, a global medical device and healthcare services group. Earlier roles in his career include CFO for Fresenius Medical Care Europe, Africa, Middle East & Latin America, Vice President for Business Development for Fresenius Medical Care Asia Pacific, and Head of Investor Relations for Fresenius Medical Care. Angelo Moesslang holds a Doctorate in Business Administration from the University of Hohenheim and a Master’s Degree in Economics from the Ludwig-Maximilian University of Munich.


Ron Stubbers, MBA

Ron Stubbers, MBA, is President of InGeneron focusing on the company’s product development, engineering, quality and regulatory activities. Mr. Stubbers has over 25 years of experience in operations, engineering and management of quality and regulatory affairs, product development and design and manufacturing engineering. Throughout his career Mr. Stubbers has contributed to the development and expansion of companies through organic growth and M&A.

Fabian Alt, M.Sc.
Chief Financial Officer

Fabian Alt, M.Sc., is Chief Financial Officer of InGeneron. Previously, he worked at Goldman Sachs in the Investment Banking Division in London. His experience extends across more than 20 completed capital market and M&A transactions, including several equity capital offerings and IPOs with >$500m deal value. Mr. Alt holds a M.Sc. Finance from the London School of Economics and Political Science (LSE), earned an Honors Master in Technology Management from the TU Munich/LMU Munich and received a Diploma/M.Sc. in Physics after studying at TU Munich and research stays at the Max-Planck-Institute for Quantum Optics and Massachusetts Institute of Technology (MIT).


Glenn Winnier, PhD
Chief Science Officer

Glenn Winnier, PhD, is Chief Science Officer of InGeneron. Dr. Winnier has over 15 years of experience in scientific leadership and a proven track record in the design of studies which have led to the successful commercialization of novel therapeutics. Previously, he worked for Memorial Hermann, Houston Methodist Research Institute, Opexa Therapeutics, and Lexicon Genetics where he gained experience in disciplines ranging from the development of intellectual property to regulatory affairs, cGMP manufacturing, and clinical trial management. Glenn Winnier holds a PhD in cell biology from Vanderbilt University.